Further studies should be conducted to evaluate the impact of increased SAA1 on the NF-κB pathway in the bone marrow microenvironment of AML patients, particularly in hematopoietic stem cells, and its relationship with the leukemic transformation process [29]. Here, SAA1 is linked to acute myeloid leukemia.